Cetera Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.89M | Buy |
65,670
+1,407
| +2% | +$40.5K | 0.01% | 843 |
|
|
2023
Q4 | $2.11M | Sell |
64,263
-3,790
| -6% | -$124K | 0.03% | 487 |
|
|
2023
Q3 | $1.9M | Buy |
68,053
+182
| +0.3% | +$5.07K | 0.03% | 483 |
|
|
2023
Q2 | $2.31M | Buy |
67,871
+924
| +1% | +$31.5K | 0.04% | 416 |
|
|
2023
Q1 | $2.01M | Sell |
66,947
-510
| -0.8% | -$15.3K | 0.03% | 451 |
|
|
2022
Q4 | $1.9M | Sell |
67,457
-2,015
| -3% | -$56.9K | 0.03% | 459 |
|
|
2022
Q3 | $2.28M | Buy |
69,472
+5,930
| +9% | +$195K | 0.06% | 329 |
|
|
2022
Q2 | $2M | Buy |
63,542
+21,745
| +52% | +$685K | 0.05% | 376 |
|
|
2022
Q1 | $1.92M | Buy |
41,797
+5,505
| +15% | +$253K | 0.04% | 426 |
|
|
2021
Q4 | $2.22M | Sell |
36,292
-36,595
| -50% | -$2.24M | 0.05% | 370 |
|
|
2021
Q3 | $5.45M | Buy |
72,887
+15,664
| +27% | +$1.17M | 0.11% | 199 |
|
|
2021
Q2 | $5.29M | Sell |
57,223
-3,384
| -6% | -$313K | 0.13% | 175 |
|
|
2021
Q1 | $5.38M | Buy |
60,607
+21,919
| +57% | +$1.94M | 0.15% | 143 |
|
|
2020
Q4 | $3.61M | Buy |
38,688
+19,394
| +101% | +$1.81M | 0.12% | 178 |
|
|
2020
Q3 | $1.23M | Buy |
19,294
+15,064
| +356% | +$960K | 0.05% | 332 |
|
|
2020
Q2 | $221K | Buy |
+4,230
| New | +$221K | 0.01% | 816 |
|
|
2019
Q2 | – | Sell |
-1,740
| Closed | -$57K | – | 940 |
|
|
2019
Q1 | $57K | Buy |
+1,740
| New | +$57K | ﹤0.01% | 956 |
|